Prognos Rare Disease
Rare diseases
CommercialActive
Key Facts
About Prognos
Prognos Health operates a data marketplace and analytics platform that provides the life sciences industry with access to harmonized, analytics-ready clinical and genomic laboratory data on over 325 million patients. The company leverages AI and machine learning to enrich this data, enabling clients to accelerate commercial strategies, target healthcare providers, and understand patient journeys in areas like oncology and rare disease. Founded in 2013, Prognos positions itself as a trusted data partner, helping pharmaceutical companies bring therapies to market faster and improve commercial execution by bypassing lengthy traditional data ingestion processes.
View full company profileTherapeutic Areas
Other Rare diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| Drug Development Program | MindMaze Therapeutics | Research |
| RareScan | Constantiam Bio | Research |
| Undisclosed Rare Disease Program(s) | Base4 | Preclinical |
| PEPRX101 | Peptris Technologies Private | In-vitro |